04UA37Z
Supplement Renal Artery, Left to No Qualifier with Autologous Tissue Substitute, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | 4 Lower Arteries |
| Operation | U Supplement |
| Body Part | A Renal Artery, Left |
| Approach | 3 Percutaneous |
| Device | 7 Autologous Tissue Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part
Procedure Overview
Supplement procedures reinforce or augment an artery using additional biological or synthetic material without removing the native vessel segment, distinguishing them from Replacement, where the diseased tissue is excised. In the lower arteries this typically takes the form of patch angioplasty at an endarterectomy site, or endovascular placement of a covered stent graft that lines and reinforces a weakened or aneurysmal segment while the native artery remains in place.
Patients undergo this type of procedure when an artery has been narrowed by plaque removal and needs a widening patch to prevent restenosis, or when an aneurysm needs endoluminal reinforcement rather than open resection. It is common in both open vascular surgery and increasingly in endovascular aneurysm repair, where covered stent grafts are deployed to reinforce the arterial wall from within.
Anatomy & Axis Detail
Renal Artery, Left
The left renal artery originates from the aorta at a slightly higher level than the right and passes a shorter, more direct course posterior to the left renal vein to enter the kidney at its hilum. When supplemented, the vessel wall is reinforced with graft material, patch angioplasty, or autologous tissue to address an aneurysm, a dissection flap, or thinning that follows balloon angioplasty or stent placement for renal artery stenosis. Because this artery is a common site for fibromuscular dysplasia and atherosclerotic disease affecting a solitary or dominant kidney, careful attention to the resulting luminal caliber is important to sustain adequate renal blood flow and glomerular filtration. Coders should note laterality carefully since bilateral renal artery pathology is frequently managed in staged procedures.
Approach: Percutaneous
Percutaneous describes entry by needle or instrument puncture through the skin or mucous membrane to reach the site of the procedure, without cutting the tissue open or using a visualizing scope. It differs from Open in that the site itself is never exposed, and from Percutaneous Endoscopic in that no endoscope is used to see internal structures. Common examples include needle biopsies and injections.
Device: Autologous Tissue Substitute
Autologous Tissue Substitute identifies a device value where material harvested from the patient's own body, such as an autograft, is used to replace or reconstruct a body part. Its defining feature is tissue origin from the patient, setting it apart from Nonautologous Tissue Substitute, sourced from a donor or animal, and Synthetic Substitute, made of manufactured material.
Coding & Documentation
Coders should confirm from the operative note that the native artery segment was left in place and that material, whether a bovine pericardial patch, synthetic patch, or covered endograft, was added to reinforce or widen it. The device value must reflect the specific material used, and the body part value should reflect the arterial segment being reinforced, which for endovascular aneurysm repair can span multiple named segments requiring multiple codes.
A frequent error is coding patch angioplasty performed after an endarterectomy as part of the Extirpation code for the plaque removal rather than as a separate Supplement code, when current guidance requires both steps to be captured. Another common mistake is applying Replacement device values to what is actually a reinforcing supplement.